Inventor · disambiguated record
K. Roger Aoki
Also filed as: AOKI K R · AOKI K ROGER
27 granted patents·13 pending applications·1,239 citations·filing 1990–2012
98Inventor score
Top patents by PatentIndex Score
40 records- 0199US6458365B1Method for treating headacheALLERGAN INC·Filed 2000·Granted Oct 1, 2002·259 cites·14 claims
- 0298US6841156B2Method for treating muscle spasm with botulinum toxin type BALLERGAN INC·Filed 2001·Granted Jan 11, 2005·112 cites·1 claims
- 0397US7223577B2Post-translational modifications and Clostridial neurotoxinsALLERGAN INC·Filed 2005·Granted May 29, 2007·48 cites·8 claims
- 0497US6974578B1Method for treating secretions and glands using botulinum toxinALLERGAN INC·Filed 1996·Granted Dec 13, 2005·121 cites·12 claims
- 0597US6872397B2Method for treating neuromuscular disorders and conditions with botulinum toxin types A and BALLERGAN INC·Filed 2001·Granted Mar 29, 2005·117 cites·5 claims
- 0697US6861058B2Method for treating essential tremor with botulinum toxin type BALLERGAN INC·Filed 2001·Granted Mar 1, 2005·68 cites·10 claims
- 0797US6683049B1Method for treating a cholinergic influenced sweat glandALLERGAN INC·Filed 2000·Granted Jan 27, 2004·79 cites·6 claims
- 0897US6645496B2Method for treating tardive dyskinesia with Botulinum toxin type BALLERGAN SALES INC·Filed 2001·Granted Nov 11, 2003·63 cites·8 claims
- 0997US6319505B1Method for treating dystonia with botulinum toxin types C to GALLERGAN SALES INC·Filed 2000·Granted Nov 20, 2001·67 cites·3 claims
- 1097US6290961B1Method for treating dystonia with botulinum toxin type BALLERGAN INC·Filed 2000·Granted Sep 18, 2001·82 cites·8 claims
- 1196US6896886B2Use of botulinum toxins for treating various disorders and conditions and associated painALLERGAN INC·Filed 2001·Granted May 24, 2005·49 cites·6 claims
- 1296US6887476B2Method for treating pain with botulinum toxin type BALLERGAN INC·Filed 2001·Granted May 3, 2005·42 cites·4 claims
- 1395US6776992B2Methods for treating tension headacheALLERGAN INC·Filed 2002·Granted Aug 17, 2004·36 cites·4 claims
- 1494US7091176B2Methods for treating arthritis painALLERGAN INC·Filed 2003·Granted Aug 15, 2006·26 cites·10 claims
- 1589US7501130B2Methods for treating myofascial painALLERGAN INC·Filed 2006·Granted Mar 10, 2009·5 cites·2 claims
- 1687US9072736B2Treatment of painFOSTER KEITH·Filed 2012·Granted Jul 7, 2015·8 cites·22 claims
- 1785US8119767B2Post-translational modifications and clostridial neurotoxinsSTEWARD LANCE E·Filed 2007·Granted Feb 21, 2012·4 cites·1 claims
- 1885US8052980B2Use of the neurotoxic component of a botulinum toxin for treating arthritisALLERGAN INC·Filed 2009·Granted Nov 8, 2011·2 cites·9 claims
- 1985US7888469B2Post-translation modification and clostridial neurotoxinsALLERGAN INC·Filed 2007·Granted Feb 15, 2011·4 cites·11 claims
- 2084US6632433B2Method for treating cervical dystonia with botulinum toxin type BALLERGAN INC·Filed 2001·Granted Oct 14, 2003·7 cites·11 claims
- 2183US8017741B2Chimera botulinum toxin type EFERNANDEZ-SALAS ESTER·Filed 2010·Granted Sep 13, 2011·3 cites·12 claims
- 2280US8008465B2Nucleic acids encoding chimera botulinum toxin type EALLERGAN INC·Filed 2010·Granted Aug 30, 2011·2 cites·12 claims
- 2379US7893202B1Post-translational modifications and Clostridial neurotoxinsALLERGAN INC·Filed 2007·Granted Feb 22, 2011·4 cites·13 claims
- 2478US8486886B2Botulinum toxin treatmentsAOKI K ROGER·Filed 2012·Granted Jul 16, 2013·2 cites·3 claims
- 2576US7691983B2Chimera botulinum toxin type EALLERGAN INC·Filed 2005·Granted Apr 6, 2010·11 cites·12 claims
- 2671US2009123498A1Treatment of post-stroke muscle painALLERGAN INC·Filed 2008·Application pending·0 cites
- 2770US2008096822A1Use of the Neurotoxic Component of a Botulinum ToxinALLERGAN INC·Filed 2007·Application pending·0 cites
- 2868US2007202129A1Use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contractureALLERGAN INC·Filed 2007·Application pending·0 cites
- 2968US2008004219A1Method for treating smooth muscle disorders with a neurotoxic component of a botulinum toxinALLERGAN INC·Filed 2007·Application pending·0 cites
- 3068US2008107763A1Use of the neurotoxic component of a botulinum toxin for treating a spastic muscleALLERGAN INC·Filed 2007·Application pending·0 cites
- 3168US2008003318A1Neurotoxic component of a botulinum toxinALLERGAN INC·Filed 2007·Application pending·0 cites
- 3268US2008107762A1Neurotoxin component treatment for spasticityALLERGAN INC·Filed 2007·Application pending·0 cites
- 3364US2005084504A1Methods for treating various disorders with a neurotoxic component of a botulinum toxinALLERGAN INC·Filed 2004·Application pending·0 cites
- 3462US2010034802A1Treatment of painSYNTAXIN LTD·Filed 2007·Application pending·0 cites
- 3556US4996209AOphthalmic antiinflammatory compositions comprising S(+)-flurbiprofenALCON LAB INC·Filed 1990·Granted Feb 26, 1991·18 cites·3 claims
- 3655US2005129716A1Therapeutic use of botulinum toxins types A and BFiled 2004·Application pending·0 cites
- 3749US2002010138A1Treatment of neuromuscular disorders and conditions with different botulinumALLERGAN INC·Filed 2001·Application pending·0 cites
- 3844US2013330369A1Reduction Of Antibody Response Against Botulinum Neurotoxin And Variants ThereofATASSI M ZOUHAIR·Filed 2011·Application pending·0 cites
- 3940US2001021695A1Multiple botulinum toxins for treating neuromuscular disorders and conditionsALLERGAN INC·Filed 2001·Application pending·0 cites
- 4030US5457126AUse of lodoxamide to treat ophthalmic allergic conditionsALCON LAB INC·Filed 1994·Granted Oct 10, 1995·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →